MedTrace Logo

National Evaluation of PI-based 2nd Line Efficacy in Cambodia

NCT01801618 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15001351

Last updated 2016-07-21

No results posted yet for this study

Summary

Medium and long term efficacy of PI-based 2nd line antiretroviral (ARV) therapy in Cambodia is poorly documented when the numbers of patients on treatment and their duration are increasing. For patients in treatment failure , there is no alternative ARV regimen available to date.

This operational research aims to evaluate the Cambodian National Program PI-based 2nd line antiretroviral regimen to assess the proportion of treatment failure and drug resistance ;identify the structural and individual factors associated with treatment failure ; design alternative salvage ARV regimens.

Conditions

Sponsors & Collaborators

  • ANRS, Emerging Infectious Diseases

    lead OTHER_GOV

Principal Investigators

  • Vonthanak Saphonn, MD · Cambodian National Center of HIV/AIDS, Dermatology and STDs (NCHADS)

  • Eric Nerrienet, MD · Institut Pasteur, Paris France

  • Bruno Spire, MD · Observatoire Régional de la Santé, Marseille, France

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2014-07-31
Completion
2014-12-31

Countries

  • Cambodia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01801618 on ClinicalTrials.gov